A Study to Learn About the Study Medicine Called PF-08046032 in People With Advanced Cancers
Pfizer
Pfizer
Immorna Biotherapeutics, Inc.
University of Southern California
M.D. Anderson Cancer Center
Ankyra Therapeutics, Inc
H. Lee Moffitt Cancer Center and Research Institute
Jonsson Comprehensive Cancer Center
Novartis
OncoNano Medicine, Inc.
H. Lee Moffitt Cancer Center and Research Institute
Memorial Sloan Kettering Cancer Center
Rutgers, The State University of New Jersey
University Health Network, Toronto
DEKA Biosciences
Columbia University
Turnstone Biologics, Corp.
Revolution Medicines, Inc.
Checkpoint Therapeutics, Inc.
Yale University
Rockefeller University
National Cancer Institute (NCI)
Rakuten Medical, Inc.
Immorna Biotherapeutics, Inc.
Bristol-Myers Squibb
H. Lee Moffitt Cancer Center and Research Institute
H. Lee Moffitt Cancer Center and Research Institute
University of California, Irvine
Revolution Medicines, Inc.
University of Zurich
BioNTech SE
Novartis
Celgene
Al-Azhar University
PCI Biotech AS
Massachusetts General Hospital
Case Comprehensive Cancer Center
sigma-tau i.f.r. S.p.A.
Santa Maria Biotherapeutics
University of Arizona
BIND Therapeutics
Blaze Bioscience Australia Pty Ltd
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Calando Pharmaceuticals
Tufts Medical Center
Case Comprehensive Cancer Center
Roswell Park Cancer Institute
Fujian Longhua Pharmaceutical Co. Ltd
NS Pharma, Inc.
NIH AIDS Clinical Trials Information Service